Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the American Medical Directors AssociationReferences
- Asymptomatic bacteriuria, antibiotic use, and suspected urinary tract infections in four nursing homes.BMC Geriatr. 2012; 12: 73
- Prolonged antibiotic treatment in long-term care: Role of the prescriber.JAMA Intern Med. 2013; 173: 673-682
- Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities.CMAJ. 2017; 189: E851-E860
- Antibiotic use among residents receiving skilled nursing care in 29 U.S. nursing homes.J Am Geriatr Soc. 2021; 69: 399-406
- Use of electronic pharmacy transaction data and website development to assess antibiotic use in nursing homes.BMC Med Inform Decis Mak. 2021; 21: 148
- Pennsylvania Department of State—Professional Licensing.(Available at:) (Accessed February 13, 2021)
- Missouri Division of Professional Registration.(Available at:) (Accessed February 13, 2021)
- eLicense Ohio Professional Licensure.(Available at:) (Accessed February 13, 2021)
- Funnel plots for comparing institutional performance.Stat Med. 2005; 24: 1185-1202
- Research in action: Using positive deviance to improve quality of health care.Implement Sci. 2009; 4: 25
Article info
Publication history
Footnotes
This work was supported in part by funds and facilities provided by the Geriatric Research Education and Clinical Center (GRECC) at the VA Northeast Ohio Healthcare System, Cleveland, OH, USA. The findings and conclusions in this document are those of the authors, who are responsible for its content, and do not necessarily represent the views of the VA or of the United States Government.
R.J. is the principal investigator on research grants from the Pfizer and Merck; she has also participated in advisory boards for Pfizer. The authors declare no conflicts of interest.